The Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV (the Panel) is accepting nominations for new scientific/clinical members with expertise in HIV medicine.

The Panel is seeking candidates with expertise and current engagement in the clinical use of antiretrovirals in infants and children, including in neonates and infants exposed to HIV.

Individuals who served as Panel members in the past are welcome to reapply. Panel members critically evaluate new information and prepare guideline revisions. The candidates should be recognized experts in their areas of interest. The successful candidates will serve a 3-year term beginning April 2024, with the potential for reappointment for an additional term. The Panel is a Working Group of the Office of AIDS Research Advisory Council (OARAC) of the National Institutes of Health. The Panel is composed of approximately 30 members who are clinicians, researchers, academicians, HHS representatives, and community representatives with expertise in HIV management in the United States. The Panel meets monthly via teleconferencing to review and critically evaluate emerging scientific data relating to antiretroviral therapy in children and revise theGuidelines for Use of Antiretroviral Agents in Pediatric HIV Infection. In addition, an Antiretroviral Subgroup meets monthly. Those with pharmacologic expertise would be expected to attend both meetings. Panel members are not financially compensated for their time commitment.

Nominations should include a curriculum vitae and a letter of interest or a letter of nomination with specific reference to how the nominee would contribute to the work of the Panel. Self-nomination is welcome. Individuals who served as Panel members in the past are welcome to reapply. Please submit all supporting documents to Segun Adeyemi, Clinicalinfo Guidelines Coordinator, at [email protected].Nominations have been extended and will be accepted until Thursday, February 29, 2024.